Published in Physician Business Week, May 27th, 2008
"In this study, we present our experience with the routine use of the MASCC risk index to determine the management of FN in our institution. Patients and methods Patients treated for solid tumours or lymphomas with low-risk FN...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.